Gene Therapy Approvals Gain Steam in 2023: Milestones in Second Half Pave Way for Transformative 2024
Gene Therapy Approvals Gain Steam in 2023: Treatments Offer New Hopes for Rare Diseases
Foodtech Patents: Who’s on the Board and What Moves are they Making?
The Evolving Gene Editing Landscape: From Research Tool to Market
Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement
Enablement Ruling Extinguishes Broad Antibody Claims, What Comes Next?
mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook
FDA Approves Coherus’ Adalimumab Biosimilar YUSIMRY™
Subscribe: Subscribe via RSS
Firm/Org